
BLFS
BioLife Solutions Inc.
$25.05
+$0.13(+0.52%)
10
Overall
--
Value
10
Tech
--
Quality
Market Cap
$1.23B
Volume
354.49K
52W Range
$19.10 - $29.55
Target Price
$31.30
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $6.4M | $8.2M | $11.0M | $19.7M | $27.4M | $48.1M | $119.2M | $161.8M | $75.9M | $82.3M | ||
Total Revenue | $6.4M | $8.2M | $11.0M | $19.7M | $27.4M | $48.1M | $119.2M | $161.8M | $75.9M | $82.3M | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $-2.6M | $-3.4M | $-4.3M | $-6.2M | $8.4M | $20.6M | $82.1M | $107.9M | $96.5M | -- | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $3.8M | $4.8M | $6.7M | $-6.2M | $19.0M | $27.4M | $37.0M | $53.8M | $45.9M | $82.3M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $-8.8M | $-9.6M | $-7.8M | $9.9M | $18.8M | $31.4M | $69.3M | $93.7M | $71.6M | $60.8M | ||
Research & Development | $1.4M | $2.0M | $1.2M | $1.3M | $3.2M | $6.7M | $11.8M | $14.8M | $12.1M | $7.9M | ||
Research Expense | $1.4M | $2.0M | $1.2M | $1.3M | $3.2M | $6.7M | $11.8M | $14.8M | $12.1M | $7.9M | ||
Selling, General & Administrative | $7.5M | $7.6M | $6.6M | $8.6M | $13.6M | $21.0M | $47.7M | $69.2M | $56.0M | $50.2M | ||
Selling & Marketing Expenses | $2.6M | $3.0M | $2.1M | $2.6M | $4.7M | $6.4M | $14.0M | $21.6M | $12.7M | $9.6M | ||
General & Administrative Expenses | $4.9M | $4.6M | $4.5M | $6.0M | $8.9M | $14.6M | $33.7M | $47.7M | $43.3M | $40.5M | ||
Promotion & Advertising | $-69.1K | $-74.9K | $-39.0K | $-30.0K | $43.0K | $167.0K | $552.0K | -- | -- | $900.0K | ||
Salaries & Wages | $-511.5K | $-777.0K | $-1.3M | $-1.5M | $3.0M | -- | -- | -- | -- | $30.9M | ||
Depreciation & Amortization | -- | $218.4K | $156.0K | $-338.0K | $1.1M | $3.0M | $8.2M | $9.7M | $3.5M | $2.7M | ||
Depreciation & Amortization | -- | $218.4K | $156.0K | $-338.0K | $1.1M | $3.0M | $8.2M | $9.7M | $3.5M | $2.7M | ||
Amortization | -- | $218.4K | $156.0K | -- | $1.1M | $3.0M | $8.2M | $9.7M | $3.5M | $2.7M | ||
Other Operating Expenses | -- | $-374.4K | -- | -- | $612.0K | $-60.0K | $-159.0K | -- | -- | $-201.0K | ||
OPERATING INCOME | ||||||||||||
Operating income | $-5.0M | $-5.1M | $-12.2M | $-16.1M | $-220.0K | $-5.6M | $-35.2M | $-145.5M | $-23.4M | $-7.1M | ||
EBITDA | $-4.7M | $-7.5M | $-2.0M | $3.5M | $-1.4M | $1.1M | $-17.8M | $-128.3M | $-13.3M | $-2.8M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | -- | $100.0K | $190.0K | $5.0K | $5.0K | -- | -- | -- | -- | -- | ||
Intinc | -- | -- | $-109.0K | $281.0K | $501.0K | $58.0K | $-485.0K | $-687.0K | $-1.4M | $-719.0K | ||
Net Non-Operating Interest Income/Expense | -- | $-100.0K | $-299.0K | $276.0K | $501.0K | $58.0K | $-485.0K | $-687.0K | $-1.4M | $-719.0K | ||
Gain on Sale of Securities | $451 | $-2.8M | -- | -- | -- | $1.3M | -- | $697.0K | -- | $-4.1M | ||
Other Income/Expense | $-21.8K | $2.9M | $-10.0M | $9.2M | $3.5M | $-3.3M | $-3.7M | $-104.2M | $-3.5M | $3.6M | ||
Other Special Charges | $21.8K | $2.4K | $11.0M | $-8.5M | $-12.8M | $3.6M | $168.0K | $704.0K | $1.3M | $497.0K | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | -- | $-100.0K | -- | $3.4M | $3.2M | -- | -- | -- | -- | -- | ||
Special Income Charges | -- | $100.0K | -- | $-3.4M | $-3.2M | -- | -- | $-110.4M | $-15.5M | -- | ||
Impairment of Capital Assets | -- | -- | -- | -- | -- | -- | -- | $110.4M | $15.5M | -- | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $-5.0M | $-7.9M | $-2.4M | $3.3M | $-3.2M | $-4.0M | $-30.6M | $-144.8M | $-25.6M | $-11.4M | ||
Pre-Tax Income | $-5.0M | $-8.0M | $-2.5M | $-25.0M | $-3.2M | $-597.0K | $-29.0M | $-144.8M | $-18.5M | $-11.4M | ||
INCOME TAX | ||||||||||||
Tax Provision | $-265.7K | $-900.9M | $-5.4M | -- | $-1.5M | $-3.3M | $-20.1M | $-5.0M | $-24.0K | $-38.0K | ||
NET INCOME | ||||||||||||
Net Income | $-4.2M | $-6.9M | $-2.5M | $-25.0M | $-1.7M | $2.0M | $-8.9M | $-139.8M | $-68.0M | $-20.2M | ||
Net Income (Continuing Operations) | $-4.2M | $-6.9M | $-2.5M | $-25.0M | $-1.7M | $2.7M | $-8.9M | $-139.8M | $-18.4M | $-11.4M | ||
Net Income (Discontinued Operations) | $-4.2M | $-6.9M | $-2.5M | $-25.0M | $-1.7M | $2.0M | $-8.9M | $-139.8M | $-68.0M | $-20.2M | ||
Net Income (Common Stockholders) | $-4.2M | $-6.9M | $-2.7M | $-25.3M | $-1.7M | $2.0M | $-8.9M | $-139.8M | $-68.0M | $-20.2M | ||
TOTALS | ||||||||||||
Total Expenses | $-11.5M | $-13.1M | $-12.1M | $3.6M | $27.1M | $49.5M | $139.0M | $201.7M | $71.6M | $60.8M | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $12.2M | $12.6M | $13.3M | $16.3M | $19.5M | $27.3M | $38.5M | $42.5M | $43.7M | $46.1M | ||
Average Shares Outstanding (Diluted) | $12.0M | $12.7M | $13.3M | $16.0M | $19.5M | $27.3M | $38.5M | $42.5M | $43.7M | $46.1M | ||
Shares Outstanding | $12.4M | $13.0M | $14.1M | $18.7M | $24.0M | $33.4M | $42.1M | $43.2M | $45.3M | $47.0M | ||
Basic EPS | -- | -- | $-0.21 | $-1.56 | $-0.09 | $0.09 | $-0.20 | $-3.29 | $-1.52 | $-0.88 | ||
Basic EPS (Continuing Operations) | -- | -- | -- | -- | $-0.09 | $0.09 | $-0.20 | $-3.29 | $-1.52 | $-0.69 | ||
Diluted EPS | $-0.35 | $-0.54 | $-0.21 | $-1.56 | $-0.09 | $-0.03 | $-0.20 | $-3.29 | $-1.52 | $-0.88 | ||
Diluted EPS (Continuing Operations) | -- | -- | -- | -- | -- | $-0.03 | $-0.20 | $-3.29 | $-1.52 | $-0.69 | ||
OTHER METRICS | ||||||||||||
Accrued Preferred Stock Dividends | -- | -- | $213.0K | $339.0K | $1.7M | $954.0K | $8.9M | $139.8M | $66.4M | -- | ||
Acquisition Expense | -- | -- | -- | -- | $940.0K | $668.0K | $1.6M | $18.0K | -- | -- | ||
Basic Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-0.19 | ||
Diluted Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | $-0.19 | ||
Earnings from equity interest | -- | -- | $-1.0M | $-672.0K | $-739.0K | -- | -- | -- | -- | -- | ||
Earnings From Equity Interest Net Of Tax | -- | -- | $-1.0M | $-672.0K | $-739.0K | -- | -- | -- | -- | -- | ||
Gain On Sale Of P P E | -- | $-1.2K | -- | -- | -- | -- | -- | -- | -- | -- | ||
Gains Loss On Disposal Of Discontinued Operations | -- | -- | -- | -- | -- | -- | -- | -- | $-193.0K | $-132.0K | ||
Interest Expense Operating | -- | -- | $-38.0K | $-5.0K | -- | -- | -- | -- | -- | -- | ||
Minority Interests | $781.4K | $1.2M | -- | -- | -- | -- | -- | -- | -- | -- | ||
Net Income Discontinuous Operations | -- | -- | -- | -- | -- | -- | -- | -- | $-49.6M | $-8.8M | ||
Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | -- | -- | -- | -- | -- | -- | $-49.4M | $-8.7M | ||
Other Gand A | $4.9M | $4.6M | $4.5M | $6.0M | $8.9M | $14.6M | $33.7M | $47.7M | $43.3M | $40.5M | ||
Other Write Down | -- | $86.7K | $108.7K | -- | -- | -- | -- | -- | -- | -- | ||
Otherunder Preferred Stock Dividend | -- | -- | $213.0K | $339.0K | $1.7M | $954.0K | $8.9M | $139.8M | $66.4M | -- | ||
Preferred Stock Dividends | -- | -- | $213.0K | $339.0K | $1.7M | $954.0K | $8.9M | $139.8M | $66.4M | -- | ||
Rent And Landing Fees | $4.9M | $4.6M | $4.5M | $6.0M | -- | -- | -- | -- | -- | -- | ||
Selling Expense | $2.6M | $3.0M | $2.1M | $2.6M | -- | -- | -- | -- | -- | -- | ||
Restruct | -- | $-100.0K | -- | $3.4M | $3.2M | -- | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | BLFS | $25.05 | +0.5% | 354.49K |
3 | ||||
4 | ||||
5 | ||||
6 |